RSV Infection
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (10)
Total enrollment: 9,221 patients across 10 trials
A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab
Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life
Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China
Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection
Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults
Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children
A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV
Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children
A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis